Send to a Friend "Sensitron, Inc. Awards Chile Distribution Rights For careTrends™ Wireless Bridge"
Sensitron Enters Latin America with Chilean Partnership.
You will send the story Sensitron, Inc. Awards Chile Distribution Rights For careTrends™ Wireless Bridge to a specified friend:
Sensitron Enters Latin America with Chilean Partnership.
SAN MATEO, Calif. – June 6, 2005 Sensitron, Inc., a wireless healthcare innovations company, awarded Chile distribution rights for its careTrends™ Wireless Bridge to Cencomex, a subsidiary of Empresas Banmedica. Cencomex will purchase the careTrends software from Sensitron and will be Sensitron’s distributor in Chile—selling the careTrends software, as well as training and assisting the end users. The careTrends system, which has been translated into Spanish for the global Spanish-speaking markets, allows the collection of accurate clinical data and its dissemination into clinical information systems.
Rajiv Jaluria, CEO and President of Sensitron, stated that, “Sensitron is pleased to have an agreement with a channel partner with vast knowledge of local infrastructure and logistics. Through Cencomex, we are now able to make a successful entry into the Chilean health market.” Pierino Gazzana, the CEO of Cencomex stated, “We are looking forward to representing such an advanced company. We are certain that Sensitron’s careTrends will immediately improve patient care through increased data accuracy and reduced transcription errors.”
Device-Agnostic System Fulfills Healthcare Providers’ Demands
Sensitron’s careTrends enables a wide array of vital signs and other clinical data to be transmitted wirelessly, via secure encryption, to any existing server-based electronic patient record. Sensitron’s patented system works with monitors from different manufacturers, including legacy systems, and is an integrated open system—which sits well with the home healthcare, nursing home and assisted living facility markets, in addition to hospitals. With Sensitron’s careTrends system, potential errors in data transmission are reduced by dating and timing all data—which creates an effective audit trail. The system directly links point-of-care medical devices with clinical information systems, thus reducing staff time and clinical risk, and allowing medical staff to maintain a higher standard of clinical care.
The careTrends system also addresses healthcare providers’ needs, including immediate access to information and reduction in paperwork. Patients’ data and trends can be presented intra-hospital, inter-hospital, at a clinician’s office, or via any web-based personal digital assistant (PDA) or telephone.
Scalable System Accommodates Multiple Locations—Thus Improving the Standard of Patient Care
The careTrends system uses a combination of wireless Bluetooth and 802.11b communications protocols for data transmission to a healthcare facility’s server. Sensitron’s enterprise software in the server collects the readings and records results according to parameters set by the clinician before presenting data to caregivers. The system is modular and can accommodate multiple locations with data communication customized per patient.
By combining vital signs data with other related clinical patient records, the clinician is armed with a complete view of the patient’s status, thus enabling him or her to make a better assessment of the patient’s overall condition.
About Cencomex (http://www.empresasbanmedica.cl)
Cencomex imports and distributes medical and pharmaceutical products in Chile. Cencomex, a Santiago, Chile-based medical company, was founded in 1987, and was acquired by Empresas Banmedica, a healthcare consortium which owns many healthcare facilities and companies throughout Chile, in 1994.
About Sensitron, Inc. (http://www.sensitron.net)
Sensitron, Inc., based in San Mateo, Calif., is a wireless healthcare innovations company that has developed the careTrends Wireless Bridge system. The patented breakthrough system minimizes transcription errors and eliminates lag time between the reading, capture, documentation and dissemination of clinical data. This is accomplished by communicating vital signs and other data from wirelessly-enabled, legacy point-of-care medical devices at the bedside. Sensitron, founded in 1997, is a privately-held company, and is backed by and in partnership with NewMarket Technology, Inc. (OTCBB: NMKT)
|
|
|
|